KRS Global Biotechnology
UEI: JWNFEU276LP8
• CAGE: 691D6
Overview
Parent Awardee
Federal Capability Statement
FDA Registered Human Outsourcing Facility of sterile intravenous admixture compounding services and non-sterile-to sterile compounding services customized for hospitals, surgery centers, physician clinics, universities and research organizations.
Keywords
Compounding, Human Outsourcing, Sterile, admixture, IV solutions
Website
Headquarters
Boca Raton, FL
United States
United States
Most Recent Award
Sept. 21, 2019
Calculating
Federal contract recipient
KRS GLOBAL BIOTECHNOLOGY, INC.
(UEI JWNFEU276LP8, CAGE 691D6)
is headquartered in Boca Raton FL.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in April 2001 and
federally registered in
January 2011.
Federal Award Analysis
KRS Global Biotechnology federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
KRS GLOBAL BIOTECHNOLOGY, INC.
Division Name
503B OUTSOURCER OF HUMAN DRUGS
UEI
JWNFEU276LP8
CAGE Code
691D6
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 12, 2001
Initial Registration
Jan. 25, 2011
Last Registration
Jan. 6, 2022
Registration Activation
Dec. 30, 2020
Registration Expiration
Dec. 30, 2021
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
FL
Country of Incorporation
USA
Employees
<500
Disaster Registry
Specific Regions
Reported NAICS
Accepts Credit Cards
Yes